(RTTNews) - British drug major AstraZeneca PLC (AZN, AZN.L) announced Thursday positive high-level results from its EMERALD-3 Phase III trial of Imfinzi (durvalumab) in combination with Imjudo (tremelimumab), lenvatinib and transarterial chemoembolisation (TACE) in embolisation-e
AstraZeneca: Imfinzi, Imjudo Combo With Lenvatinib And TACE Show Positive Phase III Trial Results
(RTTNews) - British drug major AstraZeneca PLC (AZN, AZN.L) announced Thursday positive high-level results from its EMERALD-3 Phase III trial of Imfinzi (durvalumab) in combination with Imjudo (tremelimumab),…

